The Board’s wealth of industry experience and commitment to compliance will provide an invaluable perspective to openQ and our customers.
Charlottesville, VA, San Francisco, CA, New York, NY and Paris, France (PRWEB) June 17, 2010
To support its focus on regulatory compliance in the life sciences, openQ has formed a Compliance Advisory Board. Board members include experienced veterans from some of the industry’s leading companies. Their expert guidance will help openQ continue to provide innovative and industry-leading software and data products to the marketplace.
“Compliance is dynamic and we’re looking to our advisors to help keep us ahead of our customers’ evolving needs,” said Jim Zuffoletti , President and Co-Founder of openQ. “The Board’s wealth of industry experience and commitment to compliance will provide an invaluable perspective to openQ and our customers.”
Regulatory compliance has always been an important part of the life sciences. Now, however, regulations are becoming more complex, enforcement has increased, and penalties are more severe. Compliance has become critical for anyone doing business in this industry.
openQ’s Compliance Advisory Board is extremely well positioned to provide guidance that will help openQ provide products and services that mitigate compliance risks while providing efficient and effective tools to their users. By easing the compliance burden, such as manually maintaining records of interactions with doctors, users of openQ solutions can spend their time focused on their core medical mission.
The members of the Compliance Advisory Board are:
Dr. Jann Balmer, RN PhD - Dr. Balmer was appointed as the first full-time Director for Continuing Medical Education of the University of Virginia School of Medicine in December 1990. In her role as Director for CME, the Office of Continuing Medical Education has demonstrated significant growth in meeting the educational needs of physicians and other healthcare professionals. In addition, Dr, Balmer serves as the President of the Alliance for CME. She served as the editor for the Best Practices in CME Handbook distributed by the Alliance for CME for 7 years. She also serves as a speaker at the Annual Meeting of the Alliance for CME, the CME Industry Task Force Meeting, the CME Congress, and other selected organizations.
Gabriel Lazarus - Mr. Lazarus is currently a Marketing Director at Medtronic, in the company's Latin America division, focusing on CardioVascular therapies. At Medtronic he has held a variety of postings, including successful stints in the company's European headquarters in Switzerland, a global marketing role, and a business development position. Prior to entering the medical device industry, Mr. Lazarus was a journalist at Bloomberg News.
Dr. Merrell Magelli - Dr. Merrell Magelli resides in Omaha, Nebraska and is currently Senior Director, Medical Affairs, Senior Medical Director, Drug Safety Officer at GTx, Inc. in Memphis, Tennessee. She has over 12 years of Pharmaceutical Industry Experience as a Medical Science Liaison, Team Leader, Medical Director, Senior Medical Director, and Drug Safety Officer. Prior to Industry, Dr. Magelli was the Clinical Coordinator at Children's Hospital, Omaha, NE where she was in charge of the Investigational Drug Study Program, P&T Committee Co-Chair, IRB Officer, and Board Certified Pain Specialist.
Wendy L. Yarno - Wendy L. Yarno has over 26 years experience in the pharmaceutical industry with Johnson & Johnson and Merck & Co., Inc. She most recently was the Chief Marketing Officer at Merck & Co., Inc. and retired from Merck in 2008. She is currently on the Board of Directors of St. Jude Medical, a medical device company headquartered in Minneapolis, MN, and ADial Pharmaceuticals in Charlottesville, VA. Ms. Yarno is also on the Board of Advisors of HemoShear, LLC., openQ, Inc., and the University of Virginia Patent Foundation.
For more information on openQ, the Compliance Advisory Board, or its members please visit http://www.openq.com.
Based in Charlottesville, Virginia, OpenQ helps Life Sciences companies manage compliant business processes in their Marketing and Medical Affairs organizations. OpenQ offers award winning solutions for compliant business processes focused on KOL Management, Medical Affairs Programs, Grant Funding & Study Management, and Speaker Programs. OpenQ’s solutions currently support compliance initiatives at 8 of the Top 10 Pharmaceutical and 3 of the Top 5 Medical Device Companies. For more information, visit http://www.openq.com.
# # #